Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pneumococcal Conjugate Vaccine (Prevnar; Wyeth) With Pneumococcal Polysaccharide Vaccine (23-valent) and Tetanus/Diphtheria Vaccine

NCT00164411 is registered in ClinicalTrials.gov with Centers for Disease Control and Prevention as lead sponsor.

NCT NCT00164411
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00164411 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pneumococcal Conjugate Vaccine (Prevnar; Wyeth) With Pneumococcal Polysaccharide Vaccine (23-valent) and Tetanus/Diphtheria Vaccine
Lead sponsor
Centers for Disease Control and Prevention
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2004
Completion date
March 31, 2005
Enrollment
30
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pneumococcal infections